Therapeutic Antibodies – News and Features
Endometrial Cancer Combination Therapy Shows Promising Results in Trial
Patients with advanced endometrial cancer saw a significant reduction in disease growth with the combination immunotherapy and chemotherapy.
Scientists Discover How Gut Microbiomes Influence the Effectiveness of Immunotherapy
Researchers have discovered how healthy bacteria can escape the intestine, travel to lymph nodes and cancerous tumors elsewhere in the body, and boost the effectiveness of certain immunotherapy drugs.
First Nasal Antibody Treatment for COVID-19 Shows Promise Against Other Diseases
The anti-CD3 antibody drug used to treat COVID-19 has been trialed to treat other diseases and has been shown to reduce brain inflammation in multiple sclerosis patients.
Immunotherapy Before and After Surgery Improves Outcomes for High-Risk Melanoma
Starting the immunotherapy drug pembrolizumab before surgery, instead of waiting until after surgery, significantly improves the outlook for patients with high-risk melanoma.
“Dead Zone” Within Tumors Helps Cancers Spread
New research has highlighted the role of a tumor's necrotic core in promoting metastasis, linking necrosis, circulating tumor cells and metastasis.
Progress in Glycobiology: Building on Foundations and Continuing Momentum
This article walks through some of the foundational developments in the field of glycobiology that have powered the progress made in 2022 and what these advancements signal for the future.
Applications of Mass Spectrometry in Biopharmaceutical Analysis
This article will review the latest applications of mass spectrometry-based techniques across the stages of biopharmaceutical development and testing.
Cancer-Killing Virus Treatment Shows Promise in Aggressive Breast Cancer
An oncolytic virotherapy has shown promise for treating triple-negative breast cancer.
Anti-Cancer Antibodies Boosted by Reducing Their Grip
New research from the Centre of Cancer Immunology has shown that changing how tightly an antibody binds to a target could improve treatments for cancer.
Streamlining Lead Identification
To learn more about the Pioneer Antibody Discovery Platform and its potential impact on drug discovery and development, we spoke to Dr. John Cardone.